Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease

Part of paid clinical trials in Scottsdale, Arizona.

Sponsor
Mayo Clinic
Study ID
NCT06751069
Status
Recruiting

Conditions

  • Lung Fibrosis
  • Lung Interstitial Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Home-based Pulmonary Rehab — BEHAVIORAL
    Participants are expected to engage in the home-based PR routine five to six days a week for the entire 12-week study period. The PR routine begins with slow upper body and timed breathing exercises, followed by two slow balance walks for 6 minutes each. The total exercise time is 24 minutes a day followed by a 4-minute mindful breathing meditation/cool down. Exercises may be modified or repeated according to baseline activity level and as conditioning improves.

Study Details

The purpose of this clinical trial is to determine the impact of a home-based pulmonary rehabilitation program with health coaching on patient-reported respiratory-related quality of life and physical activity, as compared to usual care in patients with fibrotic interstitial lung disease.

Key Dates

Start date
Mar 3, 2025
Status verified
Mar 2026
Primary completion
Jul 1, 2030
Completion
Sep 30, 2030

Study Design

Enrollment
460 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Home-based Pulmonary Rehabilitation with Health Coaching Group
    Twelve-week intervention with home-based pulmonary rehabilitation and health coaching.
  • No Intervention: Non-use Waitlist Control Observation Group
    12-week non-use usual care waitlist with transition to intervention group at the end of the observation period.

Primary Outcome Measure

King's Brief Interstitial Lung Disease (K- BILD) [ Time Frame: Baseline, end of intervention (3 months), and 3 months post-intervention ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
Mayo Clinic in ArizonaScottsdaleArizona85259
Ana Zamora Martinez, MD (PRINCIPAL_INVESTIGATOR)
Mayo Clinic in FloridaJacksonvilleFlorida32224
Hassan Z Baig, MD (PRINCIPAL_INVESTIGATOR)
University of MinnesotaMinneapolisMinnesota55455
Scott Rajala
612-624-8511
Hyun Kim, MD (PRINCIPAL_INVESTIGATOR)
Mayo Clinic in RochesterRochesterMinnesota55905
Johanna Hoult, MS
507-293-1989
Teng Moua, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Scottsdale, AZ

Related Studies